The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2017

Filed:

Dec. 18, 2013
Applicant:

National Institute of Advanced Industrial Science and Technology, Tokyo, JP;

Inventors:

Takashi Sato, Tsukuba, JP;

Yasunori Chiba, Tsukuba, JP;

Hiroaki Tateno, Tsukuba, JP;

Hiroyuki Kaji, Tsukuba, JP;

Masanori Goto, Tsukuba, JP;

Hisashi Narimatsu, Tsukuba, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/42 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 14/42 (2013.01); G01N 33/5308 (2013.01); G01N 2333/42 (2013.01); G01N 2400/00 (2013.01);
Abstract

[Problem] The purpose of the present invention is to stably supply high-quality and highly uniformagglutinin (WFA) that recognizes biologically important sugar-chain markers, to elucidate the sugar-chain recognition activity in detail, and to furthermore increase the specificity of the sugar-chain recognition activity. [Solution] The present invention involves the development of a technique for cloning genes for codingagglutinin (WFA) and producing recombinant WFA having the same sugar-chain recognition activity as natural WFA from transformed bacteria. Natural WFA is reduced to thereby manufacture a reduced WFA monomer for specifically recognizing terminal GalNAc residue. A recombinant monomer WFA for recognizing LDN (GalNAcβ1, 4GlcNAc) sugar chain, which is important as a diagnostic marker among sugar chains having a terminal GalNAc residue, is manufactured by introducing cysteine mutation to recombinant WFA or by C-terminal-side amino acid deletion.


Find Patent Forward Citations

Loading…